Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
29.32
+1.79 (6.50%)
Jul 9, 2026, 11:17 AM EDT - Market open
Damora Therapeutics Employees
Damora Therapeutics had 7 employees as of December 31, 2025. The number of employees increased by 2 or 40.00% compared to the previous year.
Employees
7
Change (1Y)
2
Growth (1Y)
40.00%
Revenue / Employee
n/a
Profits / Employee
-$33,584,143
Market Cap
1.80B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 7 | 2 | 40.00% |
| Dec 31, 2024 | 5 | -8 | -61.54% |
| Dec 31, 2023 | 13 | -32 | -71.11% |
| Dec 31, 2022 | 45 | 5 | 12.50% |
| Dec 31, 2021 | 40 | 12 | 42.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| UroGen Pharma | 298 |
| Zymeworks | 243 |
| Maze Therapeutics | 141 |
| AnaptysBio | 104 |
| Bicara Therapeutics | 103 |
| AtaiBeckley | 99 |
| Tyra Biosciences | 87 |
DMRA News
- 7 days ago - Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 22 days ago - Damora Therapeutics Transcript: AGM 2026 - Transcripts
- 4 weeks ago - Damora Therapeutics initiated with a Buy at H.C. Wainwright - TheFly
- 6 weeks ago - Wedbush bullish on Damora Therapeutics, initiates with an Outperform - TheFly
- 6 weeks ago - Damora Therapeutics initiated with an Outperform at Wedbush - TheFly
- 2 months ago - Damora Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 2 months ago - Damora Therapeutics Slides: Corporate presentation - Filings
- 2 months ago - Damora Therapeutics Quarterly report: Q1 2026 - Filings